Click here to read the articles and download the PDF

Pharmaceutical Commerce - December 2024

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Did Industry Fumble the DSCSA Deadline?

A crash course on the bubble itself, including therapeutic areas most affected.

Going Inside the Gross-to-Net Bubble and Its Nuances

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Why AI Advances in CGT Require Getting Data Right

Articles

The document reiterates the company’s commitment to ESG principles, including carbon neutrality by 2030.

Tower Cold Chain Submits Its First-Ever Sustainability Report

The decision comes after success during formulation testing with convincing stability data.

TFF Pharmaceuticals, Cleveland Clinic to Move Their Influenza Vaccine Candidates into Preclinical Testing

The latest news for pharma industry insiders.

Pharma Pulse 5/22/24: A Pharmacist’s Impact on Inclusive Health Care, ChatGPT Usage to Support Drug Development & more

The agreement is expected to focus on cell manufacturing processes, with potential for sharing tech with academia, startups.

Astellas, YASKAWA Sign Cell Therapy MoU Powered by Robotics Technology

Videos

In an interview with Pharma Commerce Associate Editor Don Tracy, Ron Lanton, Partner, Lanton Law offers his thoughts on the recent Federal Trade Commission (FTC) repeal of non-compete agreements, and how it could effect the pharma industry. 

Effects of the Federal Trade Commission's Repeal of Non-Compete Agreements on the Pharma Industry

Pharma Pulse 5/21/24: Hims & Hers Announces Access to GLP-1 Injections, The Impact of the Presidential Election on Pharma & more

The facility, company says, will be its first that covers end-to-end ADC production.

AstraZeneca to Build $1.5 Billion Antibody Drug Conjugates Manufacturing Plant in Singapore

The company increases its selection of atopic dermatitis treatments in the process.

Johnson & Johnson Purchases Proteologix for $850 Million

Pharma Pulse 5/20/24: Getting Pharma Ready for Generation Alpha, Teens Ask Schools to Provide Mental Health Information & more

Leaders in the space discuss aspects of experimental drug support and more at this year’s US Pharma and Biotech Summit.  

Featured Content

Pharmaceutical Commerce - December 2024

Did Industry Fumble the DSCSA Deadline?

Going Inside the Gross-to-Net Bubble and Its Nuances

Why AI Advances in CGT Require Getting Data Right